Who is sponsoring NCT05250388?

NCT05250388 is sponsored by Catarina Malmberg.

What drugs are being tested in NCT05250388?

Interventions in NCT05250388: Arthroscopic Bankart repair.

What condition does NCT05250388 study?

NCT05250388 studies Shoulder Dislocation.

Is NCT05250388 still recruiting?

NCT05250388 is currently status unknown. Last updated 14 February 2024.

Last reviewed 2024-02-14 · How we verify

NCT05250388

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of Arthroscopic Bankart Repair on Anterior-posterior Glenohumeral Translation and Shoulder Proprioception in Patients With Traumatic Anterior Shoulder Instability: a Prospective Cohort Study

Status unknown Last updated 14 February 2024

What this trial tests

trial testing Arthroscopic Bankart repair in Shoulder Dislocation in 30 participants. Status unknown.

Timeline

1 April 2022

Primary endpoint
1 April 2025

1 April 2025

Quick facts

Lead sponsor	Catarina Malmberg
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	30
Start date	1 April 2022
Primary completion	1 April 2025
Estimated completion	1 April 2025
Sites	1 location across Denmark

Drugs / interventions tested

Arthroscopic Bankart repair

Conditions studied

Shoulder Dislocation — all drugs for Shoulder Dislocation →

Sponsor

Catarina Malmberg

Who can join

Adults 18 to 40, any sex, with Shoulder Dislocation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the study is to investigate biomechanical and proprioceptive conditions in patients with symptomatic traumatic anterior shoulder instability undergoing arthroscopic Bankart repair. To determine these, non-invasive and non-irradiating examination methods that have been proven valid and reliable will be used in a combination that has not been reported before. The objective is to determine whether the anatomical reconstruction affects biomechanical and proprioceptive measures in the traumatic unstable shoulder. The study will also investigate patient-reported and clinical outcomes. The hypotheses are that the intervention improves biomechanical and proprioceptive conditions to the near-normal state, as measured after both 6 and 12 months. Further, hypotheses are that the intervention leads to improved patient-reported and clinical outcomes.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Reliability of ultrasound measurement of glenohumeral instability.
Malmberg C, Andreasen KR, Bencke J, Kjær BH, et al · · 2025 · PMID 41133330 · DOI 10.61409/a11240835
Biomechanical and neuromuscular characteristics in patients with traumatic anterior shoulder instability undergoing arthroscopic Bankart repair: a clinical prospective cohort study protocol.
Malmberg C, Andreasen KR, Bencke J, Kjær BH, et al · · 2024 · PMID 38431300 · DOI 10.1136/bmjopen-2023-078376

Verify or expand the search:

Other recruiting trials for Shoulder Dislocation

Currently open trials in the same condition.

NCT06531590 — Anterior Shoulder Dislocation at Emergency Department · recruiting
NCT05705479 — Shoulder Instability Trial Comparing Arthroscopic Stabilization Benefits Compared With Latarjet Procedure Evaluation - S · NA · active not recruiting
NCT05715021 — RCT Evaluating First Time Shoulder Dislocation · NA · recruiting
NCT04809064 — Open Versus Arthroscopic Stabilization of Shoulder Instability With Subcritical Bone Loss: The OASIS Trial · recruiting
NCT03585491 — Shoulder Instability Trial Comparing Arthroscopic Stabilization Benefits Compared With Latarjet Procedure Evaluation · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05250388 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Catarina Malmberg
Last refreshed: 14 February 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05250388.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing